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Introduction: Obesity is the world’s most important public health problem. Adipose tissue contributes significantly
to increase pro-inflammatory mediators whose cascade begins with the union of TLR4 to its microbial ligands
(TLR: Toll Like Receptors). It has been reported recently that NEFAs (Non-Esterified Fatty Acids) bind to this
receptor as agonists. The purpose of our study was to determine the levels of expression of TLR4-CD14, the
pro-inflammatory cytokines, the metabolic markers and the NEFAs in a group of adult, non-diabetic obese Mexicans.
Method: A group of 210 adult middle-class Mexican non-diabetic obese patients was evaluated: 105 normal weight
individuals, and 105 non-diabetic obese. On both groups, the following was tested in each patient: TLR4-CD14
receptors on monocytes in peripheral blood, inflammatory profile, HOMA-IR (Homeostasis Model Assessment-Insulin
Resistance), NEFAs and each individual’s anthropometric profile.
Results: Obesity is strongly associated with the expression of TLR4 (77%, MFI (Mean Fluorescence Index) 7.70) and
CD14 (86% MFI 1.61) with 66% double positives (p = 0.000). These figures contrast with those for the normal weight
individuals that constituted the control group: TLR4 (70% MFI 6.41) and CD14 (84% MFI 1.25) with 59% double
positives. As for cytokine concentration, non- diabetic obese individuals vs the normal weight/thin, the numbers were:
IL-1β = 2.0 vs 2.5 pg/ml (p = NS), IL-6 = 36 vs 28 pg/ml (p = 0.030), IL-8 = 27 vs 27 pg/ml (p = NS), IL-10 = 8.4 vs 6.8 pg/ml
(p = NS), TNF-α =31 vs 15 pg/ml (p = 0.000) respectively. Insulin levels were 12.1 vs 19.7 mcU/ml (p = 0.000) and the
NEFAs were much higher in the obese vs normal weight/thin individuals (p = 0.000).
Conclusion: Adipose tissue used to be thought of as mere storage of fats and energy, but it has been revealed to
be an important neuro-immune-endocrine organ. Immune cells, stimulated by NEFAs, produce pro-inflammatory
cytokines, which have a direct effect on oxidating radicals that directly target the release of noradrenalin. This in turn,
reactivates the vicious cycle of low-grade chronic inflammation, as is now described in obesity.
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Obesity is a world-wide problem that increases rapidly
and can now be considered pandemic. It is considered the
main public health problem facing Mexico (ENSANUT
2012). Obese patients have been observed to suffer from
chronic low-grade inflammation as a result of the increase
in the mass of adipose tissue, which raises the production* Correspondence: mfafutis@gmail.com
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unless otherwise stated.of pro-inflammatory mediators under exogenous and/or
endogenous stimulation [1-3].
Adipose tissue (AT) used to be considered only as re-
serve tissue for fat. It is now considered an endocrine
organ capable of releasing hormones (adiponectin, leptin,
resistin, cytokines, chemokines, etc.). Additionally, AT
expresses specific receptors for these hormones and for
other molecules. In persons of normal weight, the AT is
structured with normal size adipocytes, with very little
macrophage infiltration. Obese individuals, however,
present with hypertrophied adipocytes and elevation ofMed Central Ltd. This is an Open Access article distributed under the terms of
tp://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distri-
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low-grade systemic inflammation [4-6]. It is assumed that
adipocyte hypertrophy and local hypoxia are two of the
most important factors that contribute to the accumu-
lation of macrophages in the AT of the obese [7,8]. The
macrophages of the adipose tissue (ATM) of the obese
subjects are often found arranged in “crown-like struc-
ture” (CLS) surrounding dead adipocytes [9].
The phenotype of macrophages divides into subsets
pro-(M1) or anti-inflammatory (M2). M1 phenotypes or
classically activated macrophages are induced by (lipo-
polyssacaride) LPS and TNF-α and they produce pro-
inflammatory cytokines (IL-1, IL-6 y TNF- α). IL-6 is a
cytokine relased by macrophages stimulated by noradren-
alin (NA) as part of the hypothalamus-hypophysis-adrenal
axis. This in turn releases corticosterone, modulating the
systemic inflammatory response. However, it has recently
been demonstrated in obese rats that the levels of NA are
increased and the feedback mechanism NA-IL-6 is dis-
rupted, maintaining the levels of IL-6 even in the presence
of corticosterone [10]. Thermic shock protein Hsp-72 is
also a stimuli for macrophages to release inflammatory
cytokines from both normal weight and obese rats [11].
Phenotype M2 or alternately activated macrophages
are induced by glucocorticoids, lL-4 and IL-10 and they
produce anti-inflammatory cytokines [8,12-14]. An inter-
mediate phenotype has also been described that is simi-
lar to the anti-inflammatory M2 but also secretes great
quantities of pro-inflammatory cytokines [15,16]. In
obese rats, the increase in numbers of macrophages in
the AT is similar to that which occurs in humans. In
models of rodents with diet induced obesity, there is a
change in the ATM phenotype from an M2-polarized
state in lean tissue, to a polarized-M1 state in obese
animals [17,18].
In obesity, adipocytes can release pro-inflammatory
mediators, such as quimiokine CC (CCL) -2, TNF-α and
NEFAs instead of leptin and adiponectine that promote
insulin sensitivity in a normal state [19]. Adipose tissue,
then, significantly contributes to systemic inflammatory
processes [20,21] and to insulin resistance and hyperin-
sulinemia. We therefore find a highly coordinated.
Association between inflammatory pathways and me-
tabolism [22]. This suggests an association between mac-
rophages and free fatty acids [23].
Toll receptors (TLRs) play a critical role in the in-
duction of the innate immune response in mammals via
recognition of molecular patterns associated to microbial
pathogens [24-27]. We have so far cloned 10 TLRs in
humans [28-33]. TLR ligands include lipopolysaccharide
(LPS) for TLR4. TLR4 can be activated by non-bacterial
agonists such as Hsp60, fibronectin, Taxol, cover proteins
of syncytial respiratory virus and by NEFAs [34-39]. TLRs
are type 1 transmembrane receptors characterized by thepresence of extracellular repeating motifs rich in leucine
and a cytoplasmic tail with a homologous domain to the
receptor of IL-1 (TIR) that is required to activate the
downstream signaling pathways that lead to the activation
of nuclear NF-кB that in turn promotes the increase in
pro-inflammatory cytokine production [40].
Objective
The purpose of this study was to determine the expression
of TLR4-CD14 in peripheral mononuclear cells, pro-
inflammatory cytokines, metabolic markers and NEFAs in
the serum of obese non-diabetic mestizo Mexican adults.
Materials and methods
Population characteristics
This is an analytical, descriptive study that included 210
middle-class mestizo Mexican residents of Western
Mexico. Of these, 105 were normal weigh individuals,
55 men and 50 women. The second group was also 105,
35 men and 70 women, made up of obese individuals that
did not present acute, chronic or inflammatory illnesses,
nor were they taking any kind of medication. They had all
maintained stable weight for at least 6 months. One of
the two groups was categorized as obese, with a Body
Mass Index (BMI) ≥30 kg/m2; the other group had a
BMI ≤24.99 kg/m2 and was the control group, being of
normal weight. The subjects in the obese group were non-
diabetic and presented with normal levels of cholesterol.
Table 1 shows the clinical, metabolic, and anthropometric
characteristics of all the participants in the study.
All participants were volunteers and signed an in-
formed consent form. The study was carried out in ac-
cordance with the Helsinki Declaration guidelines and
with the official Mexican norms in place regarding
health issues.
Data and sample collection
Anthropometric measurements were taken for each par-
ticipant along with weight and obesity status. The Body
Mass Index (BMI) was calculated using weight and body
size (kg/m2).
Anthropometric measurements
All anthropometric measurements were taken by the
same researcher to insure accuracy. Body Mass and size
were measured using a commercial stadiometer at the
Nuevo Leon Clinic #220, in Mexico, with a scale close to
0.2 kg and 1.0 cm, respectively. Skin fold measurements
were made with a skin fold caliper (Slim Guide Calliper)
according to the guidelines of the International Society
for the Advancement of Kineanthropometry (ISAK).
Waist/hip circumference was taken with a non elastic
measuring tape in centimeters (KaWe CE, Kirchner und
Welhelm, Germany), according to ISAK guidelines [41].
Table 1 Clinical metabolic and andtropometric
characteristic of study subjects
Non diabetic




Gender (male/ female) 35/70 55/50 -
Age (years) 38.5 ± 12.8 33.4 ± 13.4 0.006
Weight (kg) 93.4 ± 17.2 65.8 ± 9.1 0.000
BMI (kg/m2) 34.7 ± .4 23.3 ± 1.5 0.000
Body fat mass (%) 37.3 ± 6.5 23.4 ± 4.0 0.000
WHI 1.1 ± 0.3 0.8 ± 0.9 0.000
AC (cm) 109.2 ± 13.9 83.4 ± 9.6 0.000
HC (cm) 116.3 ± 14.3 98.2 ± 8.2 0.000
Time whit their
weight (years)
6.9 ± 5.4 6.4 ± 4.5 0.488
Glucose (mg/dl) 107.2 ± 9.70 81.1 ± 9.1 0.000
Chlosterol (mg/dl) 173.5 ± 40.8 161.7 ± 35.3 0.027
Triglycerides (mg/dl) 168.5 ± 139.5 126.0 ± 76.0 0.007
LDL (mg/dl) 100.2 ± 36.1 93.6 ± 29.9 0.149
HDL (mg/dl) 40.6 ± 11.5 43.1 ± 10.3 0.108
Insulin (mcU/ml) 19.7 ± 13.2 12.1 ± 3.4 0.000
HOMA-IR 5.3 ± 3.7 2.4 ± 0.7 0.000
NEFA (mEq/L) 4.7 ± 4.7 0.3 ± 0.21 0.000
Data are presented as mean ± standard deviatior. BMI: Body mass index;
WHI: Waist-hip index; AC: Abdominal circumference; HC: Hip circumference;
LDL: Low density lipoprotein; HDL: High density lipoprotein; NEFA: Non-esterified
fatty acids.
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Body fat percentage was estimated using an anthropome-
tric equation for the general population [42]. For the ge-
neral population = 0.465 + 0.180 * (S7SF) - 0.0002406 *
(S7SF)2 + 0.0661 * (age), where S7SF is the sum of the skin
folds of the chest, axila, tríceps, subscapular región, abdo-
men, suprailiac, and mid-thigh, in millimeters, and age is
expressed in years. To determine body density, we used
the Wilmore et al. equation, which for people active in
sports is 1.0988 – 0.0005 * (S7SF), where S7SF is the sum
of the skin folds from the chest, axilla (armpit), triceps,
subscapular region, abdomen, suprailiac area, and caudal
mid-thigh in millimeters [41]. Body fat was calculated
using the Siri equation (Siri/body density) – 450 [43].
Measurement of CD14 y TLR-4
Blood samples were obtained after the signing of the in-
formed consent form and were collected in test tubes
with heparin to separate the mononuclear cells of per-
ipheral blood (PBMC), and dry tubes to collect serum.
The serum samples were stored at −80°C until their use.
CD14 and TLR4 was measured with flow cytometry
using anti-CD14 antibodies (eBioscience, San Diego, CA,
USA) and anti TLR4-PE (eBioscience, San Diego, Ca,USA). Appropriate isotope controls were used for each
fluorochrome with irrelevant antibodies.
Monocyte population was identified based on size and
granular characteristics in an EPICS XL-MCL flow cyt-
ometer (Beckman Coulter, Krefeld, Germany). A total of
10,000 CD14 +monocytes was read for each sample.
The percentage of TLR4 + CD14+ monocytes was calcu-
lated from the analysis of the two fluorochromes (See
Figure 1). Data was analyzed using FlowJo software
(Arbol Star Inc., Ashland, Oregon, USA). Mean Fluores-
cence intensity (MFI) was determined subtracting the in-
tensity of the geometric mean fluorescence from the
sample control isotope.Metabolic parameters
All subjects underwent the same 12 hour fasting condi-
tions before testing. Total NEFA levels in serum were
measured by enzymatic assay (Wako, Richmond, VA). In-
sulin levels were measured using an ELISA kit (Genway
Biotech, Inc), and glucose levels were measured using a
glucometer (active Accu-Chek, Roche).Cytokines
Pro-inflammatory cytokines (IL-1β, IL-6, IL-8 and TNFα)
and the anti-inflammatory profile (IL-10) were measured
using ELISA MAX™ Deluxe Sets kits (BioLegend Inc, San
Diego, CA), according to manufacturer’s instructions.Statistics
Statistical analysis was made using the SPSS v18.0 pro-
gram and Excel 2010 software. Tests for significant diffe-
rences were made, comparing obese to normal weight.
Simple statistical comparisons were made using Student’s
“t” test. Differences were considered significant when
P <0,05 (*). All results are presented as +/− standard
deviation SD from the mean.Results
Obesity and clinical and anthropometric characteristics
The clinical and anthropometric characteristics were sig-
nificantly greater in the obese tan in the normal weight
subjects (p <0,001) (Table 1). Mean BMI in the obese
group was 34.7+/− 5.4 kg/m2 and in the normal weight
group, 23,3+/− 1,5 kg/m2 (p <0,000); percentage of fat
mass was 37,3 +/− 6,5% vs 23,4+/− 4% (p <0,000); waist
circumference 109,2+/− 13,9 cm vs 83.4 +/−9.6 cm
(p <0,000); glucose 107,2+/− 9,7 mg/dl vs 81,08+/−
9,1 mg/dl (p <0,000); triglycerides 168.5 +/−139.5 mg/dL
vs 126 +/−76 mg/dL (p <0,000); insulin 19,7+/− 13,2
MCU/ml vs 12,1 +/−3,4 MCU/ml (p <0,007) and NEFA
4,7 +/−4,7 mEq/L vs 0,25+/− 0,21 mEq/L (p <0,000),
respectively.
Figure 1 Percentage and IFM of expression TLR4 and CD14. The expression of TLR4/CD14 was more in obese then lean individuals.
a) Percentage CD14 expression. b) CD 14 mean fluorescence index. c) Percentage TLR4 expression. d) TLR4 mean fluorescence index.
e) Percentage of positive double expression CD14-TLR4. The graphs show the mean ± SD of the results.
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The percentage of TLR4 and CD14 expression in mono-
cytes of peripheral blood and the Mean Fluorescence
Index (MFI) was significantly greater in the obese
(p <0,05) than in the subjects of normal weight (Figure 1).
Inflammatory profile
The concentration of IL-6 and TNFα (36 pg/ml vs 31
pg/ml) in serum was greater in the obese and was statis-
tically more significant in comparison to the individuals
of normal weight (28 pg/ml vs 15 pg/ml), respectively
(p <0,05). The concentration of IL-1 β in serum, IL-8,
and IL-10 were not statistically significant when com-
paring obese and non- obese individuals (Figure 2).Metabolic markers
Insulin levels, HOMA-IR and NEFA measurements are
the markers we used to determine the association between
obesity and the role of the inflammatory process. The con-
centration levels of these three markers have been signifi-
cantly greater (p <0,000) in the obese than in persons of
normal weight. Insulin 19,7 +/−13,2 mcU/mL vs 12,1+/−
3,4 mcU/mL, HOMA-IR 5.3 +/−3.7 vs 2.4+/−0.7 and
NEFA 4,7 +/−4,7 mEq/L vs 0.21+/− 0.25 mEq/L, respec-
tively (Figure 3).
Discussion
Obesity is the consequence of an augment in adipose tissue,
with accompanying alteration of the immune response,
Figure 2 Serum cytokine concentration. The serum cytokine from lean and obese groups were measured by ELISA. Cytokines expressions are
shown in pg/mL for each group. Results expressed the cytokines levels on serum and are represented as means ± SD values. A strong association
of IL-6 and TNF-α with obesity was observed (*p < 0.05).
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the AT, insulin resistance and hyperinsulinemia, elevated
NEFA levels as well as elevated pro- inflammatory media-
tors (IL-1, IL-6 y TNF-α) [44-46].
Our study found: greater percentage of TLR4-CD14
expression and mean fluorescence index in monocytes,
along with elevated levels of IL-6 and TNF α in obese
adults compared to normal weight subjects. This data
coincides with the work done by Ahmad et al. [47].
The patients in this study, although non-diabetic
obese, presented insulin resistance, according to HOMA.
The elevation of this hormone is an attempt to maintain
the concentration of glucose within normal levels. ButFigure 3 Determination of metabolic markers. The metabolic study refle
higher serum levels (*p <0,000) of HOMA-IR, basal NEFAs (mEq/L), basal glyceinsulin resistance elevates NEFAs [48]. The obese pa-
tients in our study show NEFA levels 18 times higher
than the normal weight individuals. NEFAs are TLR4
agonists that might be triggering a low-grade inflamma-
tory response, as evidenced by the seric concentrations of
TNF-α and IL-6 [23]. Delving deeper into the identifica-
tion of the types of fatty acids that are being released will
permit greater understanding of the pro-inflammatory/
metabolic feedback that we found in these patients.
Adipose tissue maintains a proportion between saturated
fatty acids, palmitic and stearic acids at 22%, and mono-
unsaturated oleic at 50%. This proportion is maintained
in the adipose tissue of both obese and normal weightcted that in comparison to obese and lean individuals had significantly
mia (mg/dL) (see Table 1) and basal insulin (mcU/mL).
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rated fatty acids are the ones that produce the inflamma-
tory response and they have the capacity to express TLR-4
and TLR-2 in monocytes in vitro which would explain, in
part, the increased expression in the obese group.
Although the obese group were not diabetic, it would be
interesting to do research in vitro with TLR-4 and TLR-2
induction since high levels of glucose of 270 mg/dl, along
with high NEFA concentrations, augment the induction
effect of TLR-4, the release of Reactive Oxygen Species
(ROS), and inflammatory cytokines in human monocytes
in vitro [50]. On the other hand, it has been demonstrated
that obese individuals maintain a state of constant stress
mediated by the excess release of pro-inflammatory cyto-
kines such as ROS, in addition to physiological stress, in
which the neurotransmitter noradrenalin has a direct
effect on the immune system via specific receptors that
set up another vicious feedback cycle between the cells of
the immune system, the endocrine and the central ner-
vous system [51].
Conclusion: Adipose tissue used to be thought of as
mere storage of fats and energy, but it has been revealed to
be an important neuro-immune-endocrine organ. Immune
cells, stimulated by NEFAs, produce pro-inflammatory cy-
tokines, which have a direct effect on oxidating radicals
that directly target the release of noradrenalin. This in turn,
reactivates the vicious cycle of low-grade chronic inflam-
mation, as is now described in obesity.
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